C20ORF94 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.09060002642758E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.21440000000472E-06 |
Normal-vs-Stage2 |
2.40819999999253E-05 |
Normal-vs-Stage3 |
6.39680000080745E-08 |
Normal-vs-Stage4 |
2.19829999759114E-08 |
Stage1-vs-Stage2 |
3.578000E-01 |
Stage1-vs-Stage3 |
1.001180E-01 |
Stage1-vs-Stage4 |
2.075800E-02 |
Stage2-vs-Stage3 |
7.694600E-01 |
Stage2-vs-Stage4 |
3.443400E-01 |
Stage3-vs-Stage4 |
4.277800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.12929999795952E-08 |
Normal-vs-AfricanAmerican |
8.09389999467669E-09 |
Normal-vs-Asian |
4.352200E-01 |
Caucasian-vs-AfricanAmerican |
7.437400E-03 |
Caucasian-vs-Asian |
2.480600E-01 |
AfricanAmerican-vs-Asian |
3.509800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.42819999557642E-08 |
Normal-vs-Female |
6.27410001730055E-09 |
Male-vs-Female |
6.911600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.440000E-03 |
Normal-vs-Age(41-60Yrs) |
1.70856999999192E-05 |
Normal-vs-Age(61-80Yrs) |
1.60169988383529E-10 |
Normal-vs-Age(81-100Yrs) |
3.5953000000033E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.262400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.136800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.093800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.597800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.231800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.608200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.094600E-01 |
Normal-vs-Grade 2 |
8.23879999778399E-08 |
Normal-vs-Grade 3 |
2.12470000038323E-07 |
Normal-vs-Grade 4 |
1.20559999761127E-08 |
Grade 1-vs-Grade 2 |
2.139400E-01 |
Grade 1-vs-Grade 3 |
2.317000E-01 |
Grade 1-vs-Grade 4 |
3.725500E-02 |
Grade 2-vs-Grade 3 |
9.333200E-01 |
Grade 2-vs-Grade 4 |
3.538200E-02 |
Grade 3-vs-Grade 4 |
3.439900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.19980000004671E-06 |
Normal-vs-ccB subtype |
4.05549999999977E-05 |
ccA subtype-vs-ccB subtype |
8.207600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.02949999997359E-06 |
Normal-vs-N1 |
2.997700E-02 |
N0-vs-N1 |
8.587800E-01 |
|
|